Patent · US Active

Somatostatin-dopamine chimeric analogs

US8178651B2 · kind B2 · utility

16Cited by

18References

14Claims

0Family size

Assignee

IPSEN PHARMA S.A.S. · FR

Inventors

Michael DeWitt Culler · Gretna, US
Zheng Xin Dong · Holliston, US
Sun H. Kim · Needham, US
Jacques-Pierre Moreau · Upton, US

Key dates

Filing date	Jun 22, 2009
Grant date	May 15, 2012
Priority date	—
Expiry date	Oct 16, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is a series of somatostatin-dopamine chimeric analogs which retain both somatostatin and dopamine activity in vivo. An example is: 6-n-propyl-8β-ergolinglmethylthioacetyl-D-Phe-c(Cys-Tyr-D-Trp-Lys-Abu-Cys)-Thr-NH2.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.